USPTO serial 79271791
Serial No. 79271791
Reviewed by CopyMark Law Group
Reg. 6055780Status 706Renewal
- Filing date
- Status date
- Registration date
- May 19, 2020
- Examiner
- LEE, YATSYE ISADORA
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79271791?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kumiko Ide
Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.1150 Connecticut Avenue, NW, Suite 505WASHINGTON, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | [ Research and development relating to DNA synthesis technology; technical advisory services and * providing * information technology [ services ] relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services and * providing * information technology [ services ]relating to genome synthesis technology; research and development, quality control, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; * providing * information technology [ services ] relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; information technology services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing or research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; ] DNA synthesis services for others [ ; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; [ DNA sequence design services; ] research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 8, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Aug 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 21, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 19, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 30, 2022 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Nov 6, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 30, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 7, 2022 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 6, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 5, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 11, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 19, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 19, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 3, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 3, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 12, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 29, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 29, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 29, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 19, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 19, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 22, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 21, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |